Keywords: Flamel Technologies, Eclat Pharma, M&A, Niche brands, Generics, Financial results

Flamel Tech acquires US firm Eclat Pharma; reports loss

Article | 19 March 2012

Print This

Lyon, France-based drug delivery firm Flamel Technologies (Nasdaq: FLML) said last week that it has acquired Eclat Pharmaceuticals, a US ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in